D
D. Spaeth
Publications - 1
Citations - 119
D. Spaeth is an academic researcher. The author has contributed to research in topics: Gemcitabine & Vinorelbine. The author has an hindex of 1, co-authored 1 publications receiving 114 citations.
Papers
More filters
Journal ArticleDOI
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.
J.L. Pujol,J.-L. Breton,Radj Gervais,P. Rebattu,Alain Depierre,Jean-François Morère,B. Milleron,D. Debieuvre,D. Castera,P.J. Souquet,Denis Moro-Sibilot,Etienne Lemarié,R. Kessler,H. Janicot,D. Braun,D. Spaeth,Xavier Quantin,C. Clary +17 more
TL;DR: There was no advantage in PFS with GD compared with CV; however, the CV regimen had higher rate of toxic events, mainly myelosuppression, and the herein, non-platinum-containing regimen could be considered as a rational alternative to the cisplatin-based doublet.